Organogenesis Holdings Inc. (ORGO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-26) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-02-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-29) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Income | — |
|
| Condensed Consolidated Statements of Stockholders' Equity | — |
|
| Consolidated Statements of Redeemable Common Stock and Stockholders' Equity | — |
|
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (P) | — |
|
| Notes | ||
| Accounts Receivable, Net | ||
| Accrued Expenses and Other Current Liabilities | ||
| Acquisition | ||
| Asset Held For Sale | — |
|
| Commitments and Contingencies | ||
| Convertible Preferred Stock | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Debt Obligations | — |
|
| Earnings (loss) Per Share (eps) | ||
| Earnings Per Share (eps) | ||
| Employee Benefit Plan | — |
|
| Fair Value Measurement | ||
| Fair Value Measurement of Financial Assets and Liabilities | — |
|
| Fair Value Measurement of Financial Instruments | — |
|
| Goodwill and Intangible Assets | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Inventories | ||
| Leases | ||
| Long-lived Assets and Goodwill | — |
|
| Long-term Debt Obligations | ||
| Loss Per Share | — |
|
| Nature of Business and Basis of Presentation | ||
| Net Product Revenue | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Party Transactions | ||
| Restructuring | ||
| Revenue | ||
| Revenue From Contracts With Customers | ||
| Segment Information | ||
| Share-based Compensation | — |
|
| Significant Accounting Policies | — |
|
| Stock-based Compensation | — |
|
| Stockholders' Equity | ||
| Stockholders' Equity and Stock-based Compensation | — |
|
| Subsequent Events | ||
| Summary of Significant Accounting Policies | — |
|
| Taxes | — |
|